Amyloid Precursor Protein Processing and Alzheimer's Disease
Richard O'Brien,Philip C. Wong +1 more
TL;DR: Why Aβ accumulates in the brains of elderly individuals is unclear but could relate to changes in APP metabolism or Aβ elimination, which will be crucial to the development of therapeutic targets to treat AD.
read more
Abstract: Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau. Genetic, biochemical, and behavioral research suggest that physiologic generation of the neurotoxic Aβ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD. APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous γ-secretase complex, which also process other key regulatory molecules. Why Aβ accumulates in the brains of elderly individuals is unclear but could relate to changes in APP metabolism or Aβ elimination. Lessons learned from biochemical and genetic studies of APP processing will be crucial to the development of therapeutic targets to treat AD.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively
TL;DR: Results show that C6 glioma cell-conditioned medium (GCM), obtained from cultured astrocyte-derived C6glioma cells, inhibit Aβ1-42 production and shift APP processing towards the non-amyloidogenic pathway in APPswe-HEK293 cells, indicating that stimulation ofAstrocytic neurotrophic factors could slow AD progression.
10
Retrograde transport of masseter muscle-derived neprilysin to hippocampus.
Takuya Kobayashi,Masazumi Nagai,John D. Da Silva,Albert M. Galaburda,Sara H. Rosenberg,Wataru Hatakeyama,Yukinori Kuwajima,Hisatomo Kondo,Shigemi Ishikawa-Nagai +8 more
TL;DR: Results support the hypothesis that MM-derived NEP is transported along the TGN to reach the HPC following electrical or cholinergic stimulation, and suggest that muscle packages NEP in exosomes in response to a neuromuscular signal and sends it to the brain via retrograde axonal transport.
10
The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer's disease.
Lígia Ramos dos Santos,Jucimara Ferreira Figueiredo Almeida,Lúcia Helena Sagrillo Pimassoni,Renato Lírio Morelato,Flavia de Paula +4 more
TL;DR: An association study testing pairwise variants in metabolism, trafficking and endocytosis of lipid pathways with LOAD in samples from southeastern Brazil suggests a risk effect for LOAD between APOE with CLU and APoe with BIN1 genes.
Aβ1-42-containing platelet-derived extracellular vesicle is associated with cognitive decline in Parkinson’s disease
TL;DR: In this article , a nano-scale flow cytometry assay was used to detect PEVs and PEV-Aβ1-42 using fluorescence-labeled CD62P and Aβ 1-42 antibodies.
10
From reaction kinetics to dementia: A simple dimer model of Alzheimer's disease etiology.
TL;DR: In this paper, the authors developed a simple mathematical model linking Aβ assembly to oligomer-induced neuronal degeneration by incorporating age-dependent changes in rates of Aβ monomer production and elimination.
References
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
George G. Glenner,Caine W. Wong +1 more
TL;DR: A purified protein derived from the twisted beta-pleated sheet fibrils in cerebrovascular amyloidosis associated with Alzheimer's disease has been isolated and Amino acid sequence analysis and a computer search reveals this protein to have no homology with any protein sequenced thus far.
5.2K
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Jie Kang,H. G. Lemaire,A. Unterbeck,J. M. Salbaum,Colin L. Masters,K.-H. Grzeschik,Gerd Multhaup,Konrad Beyreuther,Benno Müller-Hill +8 more
TL;DR: An apparently full-length complementary DNA clone coding for the A4 polypeptide is isolated and sequenced and suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
4.9K
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects
TL;DR: The expectation of mental disorder shows a steep increase with advancing chronological age, and beyond 75 years a large part of this increase is accounted for by disorders associated with degenerative changes in the central nervous system for which the authors lack remedies at the present time.
4.3K
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Ganesh M. Shankar,Shaomin Li,Tapan Mehta,Amaya Garcia-Munoz,Nina E. Shepardson,Imelda M. Smith,Francesca Brett,Michael A. Farrell,Michael J. Rowan,Cynthia A. Lemere,Ciaran M. Regan,Dominic M. Walsh,Bernardo L. Sabatini,Dennis J. Selkoe +13 more
TL;DR: It is concluded that soluble Aβ oligomers extracted from Alzheimer's disease brains potently impair synapse structure and function and that dimers are the smallest synaptotoxic species.
Forecasting the global burden of Alzheimer’s disease
TL;DR: The goal was to forecast the global burden of Alzheimer's disease and evaluate the potential impact of interventions that delay disease onset or progression.